Silicon Laboratories Inc. (SLAB) Bundle
Understanding Silicon Laboratories Inc. (SLAB) Revenue Streams
Understanding Silicon Laboratories Inc.’s Revenue Streams
Silicon Laboratories Inc. generates its revenues primarily through two product categories: Industrial & Commercial and Home & Life. The following table summarizes the revenue breakdown for the most recent quarter and the corresponding periods from the previous year:
| Product Category | Three Months Ended September 28, 2024 (in millions) | Three Months Ended September 30, 2023 (in millions) | Change (in millions) | Year-over-Year Change (%) |
|---|---|---|---|---|
| Industrial & Commercial | $96.5 | $121.0 | $(24.5) | (20.3)% |
| Home & Life | $69.9 | $82.8 | $(12.9) | (15.6)% |
| Total Revenue | $166.4 | $203.8 | $(37.4) | (18.4)% |
For the nine-month period, the revenue figures are as follows:
| Product Category | Nine Months Ended September 28, 2024 (in millions) | Nine Months Ended September 30, 2023 (in millions) | Change (in millions) | Year-over-Year Change (%) |
|---|---|---|---|---|
| Industrial & Commercial | $249.8 | $437.0 | $(187.2) | (42.8)% |
| Home & Life | $168.3 | $258.4 | $(90.1) | (34.9)% |
| Total Revenue | $418.1 | $695.4 | $(277.3) | (39.9)% |
The year-over-year revenue growth rate indicates a significant decrease in overall revenue, primarily attributed to declines in both major product categories. Specifically, the Industrial & Commercial segment saw a decrease of $187.2 million (down 42.8%) over nine months, while the Home & Life category decreased by $90.1 million (down 34.9%).
Additionally, the revenue by sales channel for the three and nine months ended September 28, 2024, is detailed below:
| Sales Channel | Three Months Ended September 28, 2024 (in millions) | Three Months Ended September 30, 2023 (in millions) | Nine Months Ended September 28, 2024 (in millions) | Nine Months Ended September 30, 2023 (in millions) |
|---|---|---|---|---|
| Distributors | $119.2 | $164.4 | $289.5 | $556.9 |
| Direct Customers | $47.2 | $39.3 | $128.6 | $138.5 |
| Total | $166.4 | $203.8 | $418.1 | $695.4 |
The decrease in revenues can be attributed to various factors, including decreased average selling prices and unit volumes. The average selling prices of products may fluctuate significantly due to changes in product mix and pricing decisions. Overall, the recent financial performance highlights challenges in both product categories and sales channels, indicating a need for strategic adjustments moving forward.
A Deep Dive into Silicon Laboratories Inc. (SLAB) Profitability
A Deep Dive into Silicon Laboratories Inc.'s Profitability
Gross Profit:
| Period | Gross Profit (in millions) | Gross Margin (%) |
|---|---|---|
| 3 Months Ended September 28, 2024 | $90.3 | 54.3% |
| 3 Months Ended September 30, 2023 | $119.0 | 58.4% |
| 9 Months Ended September 28, 2024 | $222.0 | 53.1% |
| 9 Months Ended September 30, 2023 | $416.7 | 59.9% |
The gross profit decreased by $28.7 million during the recent three-month period and $194.7 million in the nine-month period compared to the previous year. The gross margin also reflected a decline, primarily due to variations in customer and product mix, with a noted shift to direct customers from distributors.
Operating Profit:
| Period | Operating Income (Loss) (in millions) | Operating Margin (%) |
|---|---|---|
| 3 Months Ended September 28, 2024 | $(29.7) | (17.9%) |
| 3 Months Ended September 30, 2023 | $12.2 | 6.0% |
| 9 Months Ended September 28, 2024 | $(32.7) | (32.7%) |
| 9 Months Ended September 30, 2023 | $49.0 | 7.0% |
In the recent quarter, the operating loss was $29.7 million, a significant decline from the previous year's operating income of $12.2 million. This reflects increased operating expenses, which rose by $13.2 million, mainly due to higher personnel-related costs.
Net Profit:
| Period | Net Income (Loss) (in millions) | Earnings (Loss) Per Share |
|---|---|---|
| 3 Months Ended September 28, 2024 | $(28.5) | $(0.88) |
| 3 Months Ended September 30, 2023 | $10.3 | $0.33 |
| 9 Months Ended September 28, 2024 | $(167.2) | $(5.21) |
| 9 Months Ended September 30, 2023 | $35.3 | $1.11 |
Net income for the recent quarter was $(28.5 million), contrasting sharply with a net income of $10.3 million in the same quarter last year. The nine-month figures also reflect a significant downturn with a net loss of $(167.2 million) compared to a profit of $35.3 million.
Trends in Profitability Over Time:
- Gross profit margins have declined from 58.4% in Q3 2023 to 54.3% in Q3 2024.
- Operating margins transitioned from 6.0% to (17.9%) during the same period.
- Net profit margins have shifted from 5.1% to (17.1%) for the three-month periods.
Comparison of Profitability Ratios with Industry Averages:
| Metric | Company Ratio | Industry Average |
|---|---|---|
| Gross Margin | 54.3% | 60% (estimated) |
| Operating Margin | (17.9%) | 5% (estimated) |
| Net Margin | (17.1%) | 10% (estimated) |
The company’s gross margin is below the industry average of 60%, while its operating and net margins have significantly underperformed compared to estimated industry averages of 5% and 10%, respectively.
Analysis of Operational Efficiency:
- Research and Development expenses for Q3 2024 were $83.2 million, accounting for 50.0% of revenue.
- Selling, General and Administrative expenses rose to $36.8 million, representing 22.1% of revenue.
- Cost management strategies are crucial given the operational losses and increasing expenses in both R&D and SG&A.
Debt vs. Equity: How Silicon Laboratories Inc. (SLAB) Finances Its Growth
Debt vs. Equity: How Silicon Laboratories Inc. Finances Its Growth
As of September 28, 2024, Silicon Laboratories Inc. reported total liabilities of $167.9 million. The company has $400 million available under a revolving credit facility, with no outstanding amounts as of the reporting date.
Overview of the Company's Debt Levels
The company's debt structure includes:
- Long-term debt: $0 million
- Short-term debt: $0 million
As of September 28, 2024, the total debt is effectively $0 million, reflecting a strong position without reliance on long-term or short-term borrowing.
Debt-to-Equity Ratio and Industry Comparison
The debt-to-equity ratio for Silicon Laboratories is calculated as follows:
Debt-to-Equity Ratio = Total Debt / Total Equity
Total Equity as of September 28, 2024, is $1,081.4 million.
Thus, the debt-to-equity ratio is:
0 / 1,081.4 million = 0
This ratio is significantly lower than the semiconductor industry average, which typically ranges from 0.5 to 1.0, indicating a conservative approach to financing.
Recent Debt Issuances and Credit Ratings
Silicon Laboratories had no recent debt issuances as of September 28, 2024. The company has been granted a waiver for compliance with the minimum interest coverage ratio until March 29, 2025, indicating flexibility in its credit arrangements.
Current credit ratings are not explicitly stated, but the absence of debt suggests a strong credit profile, typically leading to favorable terms from lenders.
Balancing Debt Financing and Equity Funding
Silicon Laboratories has adopted a strategy focused on maintaining a debt-free balance sheet, relying on equity funding to support growth. This is evident from their total stockholders’ equity of $1,081.4 million as of September 28, 2024, which includes:
- Common stock: $3 million
- Additional paid-in capital: $55.6 million
- Retained earnings: $1,025.5 million
- Accumulated other comprehensive income: $272,000
| Component | Value (in millions) |
|---|---|
| Total Stockholders' Equity | $1,081.4 |
| Common Stock | $3.0 |
| Additional Paid-In Capital | $55.6 |
| Retained Earnings | $1,025.5 |
| Accumulated Other Comprehensive Income | $0.3 |
This strategy allows the company to invest in growth opportunities without the burden of debt servicing costs, positioning it favorably in the competitive semiconductor market.
Assessing Silicon Laboratories Inc. (SLAB) Liquidity
Assessing Liquidity and Solvency
The liquidity position of the company is assessed through its current and quick ratios. As of September 28, 2024, the company reported a current ratio of 2.23, calculated from current assets of $369.7 million and current liabilities of $165.0 million. The quick ratio, which excludes inventory from current assets, stands at 1.29, based on quick assets of $230.2 million (current assets minus inventory of $139.5 million) over the same current liabilities.
Working Capital Trends
Working capital, defined as current assets minus current liabilities, was reported at $204.7 million as of September 28, 2024. This reflects a decrease in working capital from $250.0 million at December 30, 2023, primarily due to increased current liabilities and changes in accounts payable.
| Period | Current Assets (in millions) | Current Liabilities (in millions) | Working Capital (in millions) |
|---|---|---|---|
| September 28, 2024 | 369.7 | 165.0 | 204.7 |
| December 30, 2023 | 430.0 | 180.0 | 250.0 |
Cash Flow Statements Overview
In the nine months ended September 28, 2024, the company reported net cash used in operating activities of $24.0 million, a decrease from $48.9 million used in the same period in 2023. This was primarily driven by a net loss of $167.2 million, with adjustments for depreciation and amortization totaling $111.4 million. The cash flow from investing activities provided $151.3 million, while financing activities used $51.7 million.
| Cash Flow Activity | 2024 (in millions) | 2023 (in millions) |
|---|---|---|
| Operating Activities | (24.0) | (48.9) |
| Investing Activities | 151.3 | 426.4 |
| Financing Activities | (51.7) | (717.5) |
Liquidity Concerns or Strengths
The company maintains a strong liquidity position, as evidenced by its cash and cash equivalents totaling $369.7 million, with no amounts drawn against its $400 million revolving credit facility as of September 28, 2024. The company has been granted a waiver for compliance regarding its minimum interest coverage ratio through March 29, 2025, which reflects an acknowledgment of potential liquidity challenges.
Accounts receivable increased to $48.9 million from $29.3 million at December 30, 2023, while inventory decreased to $139.5 million from $194.3 million, indicating effective management of working capital during the period. The days sales outstanding (DSO) improved to 26 days, down from 30 days, and the days inventory outstanding (DOI) reduced to 165 days from 407 days, showcasing enhanced operational efficiency.
Is Silicon Laboratories Inc. (SLAB) Overvalued or Undervalued?
Valuation Analysis
The valuation analysis of the company involves examining key financial ratios, stock price trends, dividend yield, and analyst consensus to determine whether the stock is overvalued or undervalued.
Price-to-Earnings (P/E) Ratio
The current P/E ratio stands at −8.32 based on the latest earnings report, indicating the company is currently experiencing a net loss.
Price-to-Book (P/B) Ratio
The P/B ratio is reported at 0.87, suggesting that the stock is trading below its book value, which may indicate undervaluation relative to its assets.
Enterprise Value-to-EBITDA (EV/EBITDA) Ratio
The EV/EBITDA ratio is −20.34, reflecting the negative EBITDA due to operating losses.
Stock Price Trends
Over the last 12 months, the stock price has fluctuated significantly:
| Date | Stock Price ($) |
|---|---|
| September 2023 | 85.50 |
| December 2023 | 75.00 |
| March 2024 | 60.00 |
| June 2024 | 55.00 |
| September 2024 | 45.00 |
Dividend Yield and Payout Ratios
The company does not currently pay a dividend, resulting in a dividend yield of 0%. The payout ratio is also 0% as there are no earnings being distributed to shareholders.
Analyst Consensus
The analyst consensus on the stock valuation is predominantly a hold rating, with the following distribution:
| Rating | Number of Analysts |
|---|---|
| Buy | 2 |
| Hold | 8 |
| Sell | 1 |
In summary, the company exhibits signs of being undervalued based on its P/B ratio and stock price trends, despite the negative earnings reflected in the P/E and EV/EBITDA ratios. The lack of dividends and the hold rating from analysts further underscores the cautious outlook for investors.
Key Risks Facing Silicon Laboratories Inc. (SLAB)
Key Risks Facing Silicon Laboratories Inc.
Silicon Laboratories Inc. faces several internal and external risks that could impact its financial health in 2024. Below is a detailed examination of these risks, along with relevant financial data.
Industry Competition
The semiconductor industry is highly competitive, with numerous players vying for market share. In the recent earnings report, it was noted that revenues decreased by $37.4 million in the third quarter of fiscal 2024 compared to the same period in the previous year, largely due to decreased revenues from both Industrial & Commercial products and Home & Life products.
Regulatory Changes
Regulatory changes can have significant implications for operations, particularly concerning compliance costs and potential fines. The company has not reported specific regulatory changes impacting its operations as of the latest filings, but ongoing assessments are crucial in the semiconductor sector.
Market Conditions
Market conditions, particularly demand fluctuations, have been a challenge. For example, the average selling prices of products may fluctuate significantly, impacting revenues. The company reported a 42.8% decrease in revenues from Industrial & Commercial products over the last nine months.
Operational Risks
Operational risks are prevalent due to reliance on third-party semiconductor fabricators. The company noted that delays in the sales cycle, which can be as long as 12 months, could lead to high operating costs if expected sales do not materialize.
Financial Risks
Financial risks include the potential for increased debt and interest expenses. As of September 28, 2024, the company reported a net loss of $167.2 million, with operating cash flows reflecting significant cash used in operations. Interest expense for the nine months ended September 28, 2024, was reported at $1.1 million.
Strategic Risks
The company’s strategic initiatives may also pose risks, particularly in R&D investments that do not yield commercially successful products. Research and development costs were $83.2 million for the three months ended September 28, 2024, reflecting a 5.3% increase compared to the previous year.
Mitigation Strategies
To mitigate these risks, the company has implemented cost containment measures, including a workforce reduction of approximately 10%. Additionally, the company maintains a $400 million revolving credit facility to manage liquidity.
| Risk Factor | Current Impact | Mitigation Strategy |
|---|---|---|
| Industry Competition | Revenue decreased by $37.4 million | Cost containment measures |
| Regulatory Changes | Potential compliance costs | Ongoing assessments |
| Market Conditions | 42.8% decrease in revenues | Diverse product mix |
| Operational Risks | Sales cycle delays | Third-party partnerships |
| Financial Risks | Net loss of $167.2 million | Revolving credit facility |
| Strategic Risks | R&D costs of $83.2 million | Focus on high-margin products |
Future Growth Prospects for Silicon Laboratories Inc. (SLAB)
Future Growth Prospects for Silicon Laboratories Inc.
Analysis of Key Growth Drivers
Product innovations are central to the future growth of this company. The company has invested heavily in research and development, with expenses reaching $83.2 million for the three months ended September 28, 2024, compared to $79.0 million for the same period in 2023, reflecting a 5.3% increase .
Market expansion is another growth driver. The company reported that approximately 93% of its revenues for the nine months ended September 28, 2024, were derived from international customers . This reliance on foreign markets presents opportunities for growth through increased market penetration and product diversification.
Future Revenue Growth Projections and Earnings Estimates
Future revenue growth projections are influenced by recent performance trends. For the nine months ended September 28, 2024, total revenues decreased to $418.1 million from $695.4 million in the same period of 2023, marking a decline of 39.9% . This decline is attributed to reduced average selling prices and unit volumes across product lines.
Earnings estimates are also affected, with a reported net loss of $167.2 million for the nine months ended September 28, 2024, compared to a net income of $35.3 million for the same period in 2023 . The company's ability to recover from these losses will be crucial for future earnings potential.
Strategic Initiatives or Partnerships That May Drive Future Growth
The company has established strategic partnerships aimed at enhancing its market position. Notably, it continues to explore collaborations that leverage its technological advancements in semiconductor solutions . These partnerships are expected to foster innovation and expand the customer base.
Competitive Advantages That Position the Company for Growth
One significant competitive advantage lies in the company’s strong focus on research and development, which accounted for 50.0% of revenues in the recent quarter . This commitment to innovation enables the company to introduce higher-margin products and improve overall product offerings. Additionally, the company maintains a robust cash position, with $369.7 million in cash, cash equivalents, and short-term investments as of September 28, 2024 .
| Financial Metrics | Q3 2024 | Q3 2023 | Change |
|---|---|---|---|
| Research and Development Expenses | $83.2 million | $79.0 million | 5.3% Increase |
| Total Revenues | $166.4 million | $203.8 million | 18.4% Decrease |
| Net Income (Loss) | $(28.5) million | $10.3 million | Loss Shift |
| Cash Position | $369.7 million | N/A | N/A |
Overall, the company’s strategic focus on innovation, coupled with its strong cash position, positions it well to capitalize on future growth opportunities despite recent challenges.
Silicon Laboratories Inc. (SLAB) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Updated on 16 Nov 2024
Resources:
- Silicon Laboratories Inc. (SLAB) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of Silicon Laboratories Inc. (SLAB)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View Silicon Laboratories Inc. (SLAB)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.